BioSpace News Archive

CollPlant (NASDAQ: CLGN), a regenerative medicine company utilizing its proprietary plant-based rhCollagen technology for tissue repair products, today announced a clinical trial published regarding its Vergenix™STR in the treatment of tennis elbow. T

The global monoclonal antibodies market is expected to post a CAGR of over 15% during the period 2018-2022, according to the latest market research report by Technavio.

Today, the Inuit Tuberculosis Elimination Framework was released by Inuit Tapiriit Kanatami as a next step in ongoing efforts to address staggeringly high rates of tuberculosis (TB) among Inuit living in Inuit Nunangat

In November 2018, the Amgen Foundation expanded the Amgen Scholars Program (ASP) to 24 premier educational and research institutions worldwide.

An inventor from Cumming, Ga., has developed the MPAT LIFE BAND, a fully customizable, personal electronic device that can be used to monitor an individual’s overall health status.

BryoLogyx, a privately held company focused on improving on survival rates for patients with cancer announced today it has acquired exclusive rights from Stanford University for synthetic bryostatin-1 and a wide range of bryostatin analogues.

Interest in obesity medicine continues to rise as nearly 900 physicians apply for certification.

ImpediMed Limited (ASX: IPD), a global provider of medical technology to non-invasively measure, monitor and manage tissue composition and fluid status using bioimpedance spectroscopy (BIS), announces that its SOZO® Digital Health Platform was awarded the top distinction in a competitive field of ABBY-nominated semi-finalists at the ABL Organization’s 19th Innovations in Healthcare ABBY Awards

Economic growth in the United States will continue in 2019, say the nation’s purchasing and supply management executives in the December 2018 Semiannual Economic Forecast.

Covanta, (NYSE: CVA) a world leader in sustainable waste and energy solutions, has been recognized with the 2018 Sustainability, Environmental Achievement & Leadership (SEAL) for its leadership in the safe and secure destruction of unwanted and expired medication through its Prescription for Safety (Rx4Safety) program